Riskpilot← Back to searchSign inGet full accessFOSEN DYREKLINIKK AS
ASActiveOrg 8120842327190 BessakerVeterinary activities · NACE 7500Est. 20138 employeeswww.fosendyreklinikk.no
Revenue 2025
NOK 5,4M
-3% vs 2024
EBITDA margin
16.8%
+36% vs 2024
Equity ratio
57.6%
Financial strength
Net profit 2025
NOK 627K
+10% vs 2024
| Revenue | NOK 5,4M | -3% |
| EBITDA | NOK 905K | +36% |
| Net profit | NOK 627K | +10% |
| Total assets | NOK 2,6M | +25% |
| Equity | NOK 1,5M | +48% |
| Employees | 8 | — |
Legal name
FOSEN DYREKLINIKK AS
Org number
812084232
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
18. juni 2013
Share capital
NOK 200 000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Dyrlegetjenester og annen aktivitet som naturlig hører sammen med dette. Selskapet kan engasjere seg i virksomheter som står i sammenheng med dette.
Address
7190 Bessaker
Website
www.fosendyreklinikk.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 956 | 4 231 | 4 266 | 5 532 | 5 374 |
| Staff expenses | −1 756 | −1 772 | −1 934 | −2 245 | −1 886 |
| EBITDA | 221 | 321 | −151 | 664 | 905 |
| Depreciation & amort. | −151 | −159 | −176 | −0 | −84 |
| EBIT | 70 | 162 | −327 | 664 | 820 |
| Net financials | −17 | −13 | −13 | −26 | −12 |
| Profit before tax | 53 | 149 | −340 | 639 | 808 |
| Tax | 22 | 25 | −0 | 66 | 181 |
| Net profit | 31 | 124 | −340 | 572 | 627 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 514 | 1 538 | 1 217 | 2 083 | 2 606 |
| Equity | 657 | 781 | 441 | 1 014 | 1 500 |
| Long-term debt | 211 | 117 | 26 | 263 | 0 |
| Short-term debt | 646 | 640 | 750 | 804 | 897 |
| Total debt | 857 | 757 | 776 | 1 067 | 1 106 |
EBITDA margin
16.8%
This company
15.8%
Market median
+6% vs market
20212025
Equity ratio
57.6%
This company
38.2%
Market median
+51% vs market
20212025
Return on equity
41.8%
This company
18.4%
Market median
+127% vs market
20212025
Net profit margin
11.7%
This company
8.1%
Market median
+44% vs market
20212025
Asset turnover
2.06×
This company
1.12×
Market median
+84% vs market
20212025
Debt / equity
0.74×
This company
0.62×
Market median
+19% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AD Deputy Member | Deputy Member | 2013 |
HN Chief Executive Officer | Chief Executive Officer | 2013 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FOSEN DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arne Dag Bjerkaas | Deputy Member | 0 companies |
| Hilde Nordløkken | Chief Executive Officer | 0 companies |